Caricamento...
Selecting an Optimal Antiplatelet Agent for Secondary Stroke Prevention
Four seminal randomized controlled trials (RCTs) have investigated aspirin, aspirin plus extended-release dipyridamole, and clopidogrel for the prevention of recurrent vascular events. Despite studying over 32,000 patients with stroke in these trials, the decision on which antiplatelet agent to sele...
Salvato in:
| Pubblicato in: | Neurol Clin Pract |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8032446/ https://ncbi.nlm.nih.gov/pubmed/33842080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000842 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|